{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:37:12Z","timestamp":1781116632342,"version":"3.54.1"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background and aim<\/jats:title><jats:p>The MBOAT7 rs641738 (C&amp;gt;T) variant has demonstrated an association with non-alcoholic fatty liver disease (NAFLD) in both adult and pediatric patients, while few studies have been conducted in elderly populations. Hence, a case\u2013control study was undertaken to assess their correlation in elderly residents in a Beijing community.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>A total of 1,287 participants were included. Medical history, abdominal ultrasound, and laboratory tests were recorded. Liver fat content and fibrosis stage were detected by Fibroscan. Genotyping of genomic DNA was performed using the 96.96 genotyping integrated fluidics circuit.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the recruited subjects, 638 subjects (56.60%) had NAFLD, and 398 subjects (35.28%) had atherosclerotic cardiovascular disease (ASCVD). T allele carriage was associated with higher ALT (p=0.005) and significant fibrosis in male NAFLD patients (p=0.005) compared to CC genotype. TT genotype was associated with reduced risk of metabolic syndrome (OR=0.589, 95%CI: 0.114\u20130.683, p=0.005) and type 2 diabetes (OR=0.804, 95%CI: 0.277\u20130.296, p=0.048) in NAFLD population when compared to the CC genotype. In addition, TT genotype was also associated with reduced risk of ASCVD (OR=0.570, 95%CI:0.340\u20130.953, p=0.032) and less obesity (OR=0.545, 95%CI: 0.346\u20130.856, p=0.008) in the whole population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>MBOAT7 rs641738 (C&amp;gt;T) variant was associated with fibrosis in male NAFLD patients. The variant also reduced risk of metabolic traits and type 2 diabetes in NAFLD and ASCVD risk in Chinese elders.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1199429","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T14:57:29Z","timestamp":1687532249000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["MBOAT7 rs641738 (C&gt;T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiaoyi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2009.07.007","article-title":"NASH and HCC","volume":"13","author":"Page","year":"2009","journal-title":"Clinics In Liver Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American gastroenterological association, American association for the study of liver diseases, and American college of gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet (London England)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i29.6742","article-title":"Genetic factors that affect nonalcoholic fatty liver disease: a systematic clinical review","volume":"22","author":"Severson","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15738","article-title":"Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis","volume":"51","author":"Carlsson","year":"2020","journal-title":"Alimentary Pharmacol Ther"},{"key":"B10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","article-title":"Carriage of the PNPLA3 rs738409 c >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma","volume":"61","author":"Liu","year":"2014","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.12.020","article-title":"PNPLA3, TM6SF2, and MBOAT7 genotypes and coronary artery disease","volume":"152","author":"Simons","year":"2017","journal-title":"Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31238","article-title":"Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population","volume":"72","author":"Gellert-Kristensen","year":"2020","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102866","article-title":"MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD","volume":"57","author":"Meroni","year":"2020","journal-title":"EBioMedicine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3417","article-title":"A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nat Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhep.2020.08.027","article-title":"rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: a meta-analysis","volume":"74","author":"Teo","year":"2021","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320853","article-title":"Loss of hepatic Mboat7 leads to liver fibrosis","volume":"70","author":"Thangapandi","year":"2021","journal-title":"Gut"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B20","article-title":"APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD\/NASH","volume":"101","author":"Kruger","year":"2011","journal-title":"South Afr Med J = Suid-Afrikaanse Tydskrif Vir Geneeskunde"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2013a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet (London England)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet (London England)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31014","article-title":"Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease","volume":"71","author":"Kanwal","year":"2020","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.02.030","article-title":"ANGPTL3 deficiency and protection against coronary artery disease","volume":"69","author":"Stitziel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S295524","article-title":"NAFLD in the elderly","volume":"16","author":"Alqahtani","year":"2021","journal-title":"Clin Interv Aging"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32476","article-title":"Risk of liver-related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease","volume":"76","author":"Zhang","year":"2022","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2007.01614.x","article-title":"Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis","volume":"28","author":"Miyaaki","year":"2008","journal-title":"Liver Int Off J Int Assoc For Study Liver"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.006","article-title":"Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping","volume":"73","author":"Liu","year":"2020","journal-title":"J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.05.056","article-title":"A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores","volume":"20","author":"De Vincentis","year":"2022","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterological Assoc"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.07.045","article-title":"The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans","volume":"65","author":"Luukkonen","year":"2016","journal-title":"J Hepatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1038\/s41598-017-04991-0","article-title":"MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals","volume":"7","author":"Donati","year":"2017","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P067454","article-title":"Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study","volume":"58","author":"Krawczyk","year":"2017","journal-title":"J Lipid Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1038\/s41598-018-21939-0","article-title":"Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy","volume":"8","author":"Di Costanzo","year":"2018","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-018-0420-4","article-title":"). could inherited predisposition drive non-obese fatty liver disease? results from German tertiary referral centers","volume":"63","author":"Krawczyk","year":"2018","journal-title":"J Hum Genet"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185490","article-title":"Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers","volume":"13","author":"Kawaguchi","year":"2018","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14056","article-title":"Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease","volume":"33","author":"Koo","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13689","article-title":"Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children","volume":"38","author":"Lin","year":"2018","journal-title":"Liver Int Off J Int Assoc For Study Liver"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2019.01.008","article-title":"Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibility","volume":"43","author":"Xia","year":"2019","journal-title":"Clinics Res In Hepatol Gastroenterol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.02.011","article-title":"Development and validation of a scoring system, based on genetic and clinical factors, to determine risk of steatohepatitis in Asian patients with nonalcoholic fatty liver disease","volume":"18","author":"Koo","year":"2020","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterological Assoc"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16772","article-title":"NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the shanghai changfeng study","volume":"55","author":"Xia","year":"2022","journal-title":"Alimentary Pharmacol Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E12-09-0673","article-title":"LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice","volume":"23","author":"Lee","year":"2012","journal-title":"Mol Biol Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49882","article-title":"Obesity-linked suppression of membrane-bound -acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease","volume":"8","author":"Helsley","year":"2019","journal-title":"ELife"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.07.034","article-title":"Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis","volume":"15","author":"Yang","year":"2017","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterological Assoc"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26761","article-title":"Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-018-9889-3","article-title":"Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in han Chinese males","volume":"12","author":"Zhang","year":"2018","journal-title":"Hepatol Int"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2016.06.004","article-title":"PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery","volume":"12","author":"Krawczyk","year":"2016","journal-title":"Surg For Obes Related Dis Off J Am Soc For Bariatric Surg"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.04.038","article-title":"A PNPLA3 polymorphism confers lower susceptibility to incident diabetes mellitus in subjects with nonalcoholic fatty liver disease","volume":"20","author":"Moon","year":"2022","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterological Assoc"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.207373","article-title":"Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion","volume":"30","author":"Fryirs","year":"2010","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0752-7","article-title":"Apolipoprotein a-I stimulates AMP-activated protein kinase and improves glucose metabolism","volume":"50","author":"Han","year":"2007","journal-title":"Diabetologia"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckq074","article-title":"A simple risk score effectively predicted type 2 diabetes in Iranian adult population: population-based cohort study","volume":"21","author":"Bozorgmanesh","year":"2011","journal-title":"Eur J Public Health"},{"key":"B56","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12944-017-0594-3","article-title":"The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk","volume":"16","author":"Femlak","year":"2017","journal-title":"Lipids In Health Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2007.342","article-title":"Effect of obesity on high-density lipoprotein metabolism","volume":"15","author":"Rashid","year":"2007","journal-title":"Obes (Silver Spring Md.)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1319","article-title":"Relationship between nonalcoholic fatty liver disease susceptibility genes and coronary artery disease","volume":"3","author":"Brouwers","year":"2019","journal-title":"Hepatol Commun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"New Engl J Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1199429\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T14:57:35Z","timestamp":1687532255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1199429\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":59,"alternative-id":["10.3389\/fendo.2023.1199429"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1199429","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]},"article-number":"1199429"}}